Blogs

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials

By Aesthetic Multispecialty Society posted Apr 30, 2020 10:08 AM

  
.
0 comments
0 views

Permalink